LATE‐R TRIAL: A PHASE II, SINGLE‐ARM, OPEN‐LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY OF AXI‐CEL IN PATIENTS WITH LATE RELAPSE OF LARGE B‐CELL LYMPHOMAS | Publicación